Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1% of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary complication of RA and it is responsible for 10–20% of mortality, with a mean survival of 5–8 years. However, nowadays there a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassone, Giulia, Manfredi, Andreina, Vacchi, Caterina, Luppi, Fabrizio, Coppi, Francesca, Salvarani, Carlo, Sebastiani, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230307/
https://www.ncbi.nlm.nih.gov/pubmed/32290218
http://dx.doi.org/10.3390/jcm9041082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230307/
https://www.ncbi.nlm.nih.gov/pubmed/32290218
http://dx.doi.org/10.3390/jcm9041082

Ejemplares similares